Structures by: Gamouh A.
Total: 8
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=7.0748(4)Å b=8.1131(4)Å c=16.9559(9)Å
α=90° β=90° γ=90°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=6.5388(7)Å b=18.888(2)Å c=15.6064(18)Å
α=90° β=90° γ=90°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=9.2170(17)Å b=16.827(3)Å c=6.6121(13)Å
α=90° β=109.778(4)° γ=90°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=9.5041(12)Å b=10.9669(14)Å c=9.1780(12)Å
α=90° β=94.857(3)° γ=90°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=7.6034(4)Å b=14.7108(7)Å c=8.7184(4)Å
α=90° β=100.023(2)° γ=90°
3-{1-[(1-Allyl-1<i>H</i>-indazol-6-yl)amino]ethylidene}-6-methyl-2<i>H</i>-pyran-2,4(3<i>H</i>)-dione
C18H17N3O3
Acta Crystallographica Section E (2014) 70, 12 o1256
a=6.7708(11)Å b=10.5761(17)Å c=11.9643(17)Å
α=88.239(9)° β=81.123(9)° γ=79.140(9)°
<i>N</i>-(1-Acetyl-3-chloro-1<i>H</i>-indazol-6-yl)-4-methoxybenzenesulfonamide
C16H14ClN3O4S
Acta Crystallographica Section E (2015) 71, 12 o914-o915
a=13.9664(6)Å b=6.4300(3)Å c=19.6155(9)Å
α=90° β=107.2270(10)° γ=90°
<i>N</i>-(3-Chloro-1-methyl-1<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide
C15H14ClN3O3S
Acta Crystallographica Section E (2014) 70, 9 o983-o984
a=8.20230(10)Å b=10.6312(2)Å c=10.8957(2)Å
α=117.5230(10)° β=93.0950(10)° γ=103.1660(10)°